神经母细胞瘤诊断、管理与治疗进展
神经母细胞瘤是儿童最常见的颅外实体瘤,占儿童肿瘤死亡的15%。本文综述近20年神经母细胞瘤诊断、管理和治疗进展,强调术前风险分层、肿瘤基因评估及现代高质量先进影像模态的应用。
要点
- 多模态解剖成像(超声、CT、MRI)及功能或代谢核医学成像是确定神经母细胞瘤风险状态的关键。
- 患者年龄、疾病分期、组织病理学结果及多种生物学因素共同参与术前和治前风险分层。
- 低风险患者接受最小干预,高风险患者接受多模态治疗;新型免疫治疗和核医学靶向治疗在高风险患者中显示出有前景的缓解率。
核心结论
- 神经母细胞瘤预后高度可变,从自发消退到对治疗无反应的广泛转移性疾病;多模态影像和风险分层对管理至关重要。
研究设计与样本
- 综述文章,回顾近20年神经母细胞瘤诊断、管理和治疗进展,包括术前风险分层、肿瘤基因评估和现代先进影像模态的应用。
临床应用与阅片要点
- 多模态解剖成像(超声、CT、MRI)及功能或代谢核医学成像用于确定神经母细胞瘤患者的风险状态;患者年龄、疾病分期、组织病理学结果及多种生物学因素参与术前和治前风险分层。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system. It is the most common extracranial solid tumor of childhood and accounts for up to 15% of all pediatric cancer fatalities. The manifestation of neuroblastoma is variable depending on the location of the tumor and on the presence or absence of paraneoplastic syndromes. The prognosis of neuroblastoma is also highly variable, ranging from spontaneous regression to widespread metastatic disease that is unresponsive to treatment. The age of the patient, stage of disease, histopathologic results, and multiple biologic factors contribute to the presurgical and pretreatment risk stratification of a patient with neuroblastoma. Multimodality anatomic imaging with ultrasonography, computed tomography, and magnetic resonance imaging, as well as functional or metabolic nuclear imaging, are essential to determining the risk status of a patient with neuroblastoma. Patients at low risk of metastasis or death receive minimal intervention and those at high risk receive multimodality treatment. New immunotherapeutic techniques and nuclear medicine-targeted therapies have emerged and are demonstrating promising response rates for patients at high risk. This article reviews updates in the diagnosis, management, and treatment of neuroblastoma that have evolved over the past 2 decades, including emphasis on presurgical risk stratification, genetic evaluation of tumors, and the use of modern, high-quality, advanced imaging modalities. ©RSNA, 2018.
引用
- Swift CC, Eklund MJ, Kraveka JM, et al. Updates in Diagnosis, Management, and Treatment of Neuroblastoma. Radiographics. 2018. PMID: 29528815. doi:10.1148/rg.2018170132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。